Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study

Carlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, Andrea Evangelista, Francesca Maria Quaglia, Stefano Fiori, Riccardo Bomben, Maria Chiara Tisi, Marcello Riva, Anna Merli, Francesco Rotondo, Costanza Fraenza, Maria Elena Carazzolo, Paolo Corradini, Lucia Farina, Claudia Castellino, Alessia Castellino, Vittorio Ruggero Zilioli, Cristina Muzi, Francesco Piazza, Alessandro Re, Stefan Hohaus, Francesca Gaia Rossi, Gerardo Musuraca, Alice Di Rocco, Benedetta Puccini, Roberta Sciarra, Filippo Ballerini, Federica Cavallo, Riccardo Bruna, Riccardo Moia, Alessia Moioli, Andrea Bernardelli, Daniela Drandi, Annalisa Arcari, Francesco Merli, Guido Gini, Roberto Freilone, Monica Tani, Vincenzo Pavone, Marco Ladetto, Stefano Aldo Pileri, Monica Balzarotti

Open source

DOI: 10.1016/s2352-3026(25)00252-2
Published: 2025-10
Container: The Lancet Haematology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-25-00252-2,
  title = {Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL\_V-RBAC): a multicentre, single-arm, phase 2 study},
  author = {Carlo Visco and Valentina Tabanelli and Maria Vittoria Sacchi and Andrea Evangelista and Francesca Maria Quaglia and Stefano Fiori and Riccardo Bomben and Maria Chiara Tisi and Marcello Riva and Anna Merli and Francesco Rotondo and Costanza Fraenza and Maria Elena Carazzolo and Paolo Corradini and Lucia Farina and Claudia Castellino and Alessia Castellino and Vittorio Ruggero Zilioli and Cristina Muzi and Francesco Piazza and Alessandro Re and Stefan Hohaus and Francesca Gaia Rossi and Gerardo Musuraca and Alice Di Rocco and Benedetta Puccini and Roberta Sciarra and Filippo Ballerini and Federica Cavallo and Riccardo Bruna and Riccardo Moia and Alessia Moioli and Andrea Bernardelli and Daniela Drandi and Annalisa Arcari and Francesco Merli and Guido Gini and Roberto Freilone and Monica Tani and Vincenzo Pavone and Marco Ladetto and Stefano Aldo Pileri and Monica Balzarotti},
  year = {2025},
  journal = {The Lancet Haematology},
  doi = {10.1016/s2352-3026(25)00252-2},
  url = {https://doi.org/10.1016/s2352-3026(25)00252-2}
}

RIS

TY  - JOUR
TI  - Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study
AU  - Carlo Visco
AU  - Valentina Tabanelli
AU  - Maria Vittoria Sacchi
AU  - Andrea Evangelista
AU  - Francesca Maria Quaglia
AU  - Stefano Fiori
AU  - Riccardo Bomben
AU  - Maria Chiara Tisi
AU  - Marcello Riva
AU  - Anna Merli
AU  - Francesco Rotondo
AU  - Costanza Fraenza
AU  - Maria Elena Carazzolo
AU  - Paolo Corradini
AU  - Lucia Farina
AU  - Claudia Castellino
AU  - Alessia Castellino
AU  - Vittorio Ruggero Zilioli
AU  - Cristina Muzi
AU  - Francesco Piazza
AU  - Alessandro Re
AU  - Stefan Hohaus
AU  - Francesca Gaia Rossi
AU  - Gerardo Musuraca
AU  - Alice Di Rocco
AU  - Benedetta Puccini
AU  - Roberta Sciarra
AU  - Filippo Ballerini
AU  - Federica Cavallo
AU  - Riccardo Bruna
AU  - Riccardo Moia
AU  - Alessia Moioli
AU  - Andrea Bernardelli
AU  - Daniela Drandi
AU  - Annalisa Arcari
AU  - Francesco Merli
AU  - Guido Gini
AU  - Roberto Freilone
AU  - Monica Tani
AU  - Vincenzo Pavone
AU  - Marco Ladetto
AU  - Stefano Aldo Pileri
AU  - Monica Balzarotti
PY  - 2025
JO  - The Lancet Haematology
DO  - 10.1016/s2352-3026(25)00252-2
UR  - https://doi.org/10.1016/s2352-3026(25)00252-2
ER  -

APA

Visco, C., Tabanelli, V., Sacchi, M. V., Evangelista, A., Quaglia, F. M., Fiori, S., Bomben, R., Tisi, M. C., Riva, M., Merli, A., Rotondo, F., Fraenza, C., Carazzolo, M. E., Corradini, P., Farina, L., Castellino, C., Castellino, A., Zilioli, V. R., Muzi, C., Piazza, F., Re, A., Hohaus, S., Rossi, F. G., Musuraca, G., Rocco, A. D., Puccini, B., Sciarra, R., Ballerini, F., Cavallo, F., Bruna, R., Moia, R., Moioli, A., Bernardelli, A., Drandi, D., Arcari, A., Merli, F., Gini, G., Freilone, R., Tani, M., Pavone, V., Ladetto, M., Pileri, S. A., & Balzarotti, M. (2025). Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(25)00252-2

Source records

crossref · retrieved 2026-09-27T07:54:02.929Z